Search results for "GLP-1 obesity treatment"

Hanmi’s ‘Epe’ Wins MFDS Approval, Becoming South Korea’s First Homegrown GLP-1 Obesity Drug

Hanmi’s ‘Epe’ Wins MFDS Approval, Becoming South Korea’s First Homegrown GLP-1 Obesity Drug

A domestically developed therapy has entered South Korea’s obesity treatment market, long dominated by imported products such as Wegovy and Mounjaro.
Does Wegovy Triple Depression Risk? Real-World Data from Korean Hospitals Yields Nuanced Findings

Does Wegovy Triple Depression Risk? Real-World Data from Korean Hospitals Yields Nuanced Findings

A recent observational study indicates that individuals taking popular GLP-1 receptor agonist obesity medications may face an elevated risk of...
Can Eggs and Olive Oil Help You Lose Weight? Why the

Can Eggs and Olive Oil Help You Lose Weight? Why the "Natural Wegovy" Trend Can Backfire

A viral diet trend touting olive oil drizzled over boiled eggs as a "natural Wegovy" has gained traction among...
Do Wegovy and Mounjaro Count as Doping? WADA Monitors GLP-1 Drugs in Sports

Do Wegovy and Mounjaro Count as Doping? WADA Monitors GLP-1 Drugs in Sports

GLP-1 (glucagon-like peptide-1) class medications, such as Novo Nordisk’s Wegovy and Eli Lilly’s Mounjaro, are...
JW Pharmaceutical Files for Phase 3 Trial of Biweekly Obesity Drug Bofanglutide

JW Pharmaceutical Files for Phase 3 Trial of Biweekly Obesity Drug Bofanglutide

JW Pharmaceutical announced on Aug. 18 that it has submitted an Investigational New Drug application to South Korea’s...
Forget Wegovy and Mounjaro: How Hanmi’s 'EPPE' Is Redefining Obesity Care

Forget Wegovy and Mounjaro: How Hanmi’s 'EPPE' Is Redefining Obesity Care

Hanmi Pharmaceutical has officially named its in-development obesity treatment "EPPE.
Samsung Biologics Bets 2.7 Trillion Won on Peptides in South Korea’s Largest Biotech M&A Deal

Samsung Biologics Bets 2.7 Trillion Won on Peptides in South Korea’s Largest Biotech M&A Deal

Samsung Biologics is making a major push into peptide-based medicines—widely used in weight-loss and diabetes...
The Surgeon Who Shed 36kg: Why Willpower Alone Fails Against Severe Obesity

The Surgeon Who Shed 36kg: Why Willpower Alone Fails Against Severe Obesity

It is hard to believe that a cardiothoracic surgeon who repairs hearts was once a patient with "super obesity.
The Surprising Life-Saving Potential of Weight Loss Meds in Diabetic Foot Care

The Surprising Life-Saving Potential of Weight Loss Meds in Diabetic Foot Care

GLP-1 receptor agonists (such as Wegovy and Ozempic), currently dominating the headlines as weight loss medications,...
“Half the Price of Mounjaro”: South Korea’s First Homegrown Obesity Drug Epe Enters the Market

“Half the Price of Mounjaro”: South Korea’s First Homegrown Obesity Drug Epe Enters the Market

The first domestically developed obesity medication is entering South Korea’s weight-loss market, long dominated by...